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Abstract: 17 
Common symptoms of pandemic Coronavirus disease (COVID-19) include fever and 18 
cough. We describe a 94 year old man with well-controlled schizoaffective disorder, 19 
who presented with non-specific and atypical symptoms: delirium, low-grade pyrexia 20 
and abdominal pain. He was given antibiotics for infection of unknown source, 21 
subsequently refined to treatment for community-acquired pneumonia. Despite 22 
active treatment, he deteriorated with oxygen desaturation and tachypnoea. Repeat 23 
chest X-ray showed widespread opacification. Post-mortem throat swab identified 24 
COVID-19 infection. He was treated in three wards over five days with no infection 25 
control precautions. This has implications for the screening, assessment and 26 
isolation of frail older people to COVID-specific clinical facilities, and highlights the 27 
potential for spread among healthcare professionals and other patients.  28 
 29 
Introduction: 30 
The World Health Organisation characterised Coronavirus disease (COVID-19) as 31 
pandemic in March 2020 [1]. In published series 44% of patients had fever on 32 
admission and 89% developed it subsequently. Cough was present in 68%, fatigue 33 
and sputum production in about 25% [2]. Cardiac complications such as myocardial 34 
infarction or heart failure are common. Mortality rates are particularly high in older 35 
people [3]. We describe a case highlighting the need to be alert for non-specific or 36 
atypical presentations which may delayed testing, diagnosis and isolation. 37 
 38 
Case report: 39 
A 94 year old man with schizoaffective disorder was admitted to hospital in the 40 
United Kingdom in March 2020, early in the pandemic. He was found confused by 41 
his landlady. His home was untidy and cold. Emergency department assessment 42 
concluded: ‘not coping at home, possible delirium or mental relapse’. 43 
Further history was given by his daughter by telephone. He had ischemic heart 44 
disease, his schizoaffective disorder was well-controlled on valproate semisodium, 45 
and he was normally cognitively intact. He was moderately frail (Clinical Frailty Scale 46 
6), and a former smoker. He lived alone and walked with a Zimmer frame. His 47 
daughter visited four times a week, the last time three days previously, as she had 48 
been unwell with pneumonia.  49 
On arrival, his temperature was 37.4oCelsius, respiratory rate 20/minute, oxygen 50 
saturation 98% on air, blood pressure 128/70mmHg and heart rate 96/minute. He 51 
was drowsy, disorientated, trying to undress himself and resisting care. He had 52 
wheeze and crepitations on chest examination, and abdominal pain and tenderness. 53 
Blood test results included white cell count 14 (lymphocytes 0.97, neutrophils 6.3) 54 
x109g/L, C-reactive protein 258mg/L, urea 15 mmol/L, creatinine 101 micromol/L 55 
(baseline 83), lactate 3.4 mmol/L. Blood culture grew Staphylococcus epidermidis of 56 
doubtful significance. ECG showed sinus rhythm with left bundle branch block. Chest 57 
X-ray (CXR) showed no consolidation. Urine culture was negative. 58 
The initial diagnosis was delirium due to infection of unknown source and acute 59 
kidney injury. He was treated with intravenous fluids and piperacillin/tazobactam. CT 60 
abdomen with contrast showed bibasal lung consolidation. There was hypo-61 
enhancement of the cardiac apex consistent with myocardial ischemia. 62 
Echocardiogram showed a dilated left ventricle with severely impaired systolic 63 
function. Troponin was raised at 475ng/L (normal 0-59) suggesting type 2 myocardial 64 
infarction. A Do Not Resuscitate order was agreed.  65 
 66 
Antibiotics were changed to co-amoxiclav and clarithromycin following the CT scan. 67 
Three days following admission, he remained unwell: temperature 37.5o, respiratory 68 
rate 30/minute, oxygen saturation 91% on 2 litres/minute inspired oxygen. Repeat 69 
CXR showed right upper and lower zones airspace opacification in keeping with 70 
infection (Figure 1). Oxygen saturation deteriorated to 87% on 15 litres/minute of 71 
oxygen; arterial blood gas showed pO2 7.8kPa, pCO2 5.3kPa. He died 5 days 72 
following admission. A nasopharyngeal swab performed post-mortem was positive 73 
for SARS-COV-2-RNA. 74 
 75 
Seven nursing staff and one doctor subsequently developed symptoms. The patient 76 




This man living with frailty presented with non-specific features, which do not appear 81 
in the symptoms listed in published reports [2,3] or guidance [4] on COVID-19. He 82 
developed lower respiratory signs and was treated for bacterial pneumonia. His 83 
temperature was always below 37.8oC, the diagnostic criterion for COVID-19. He 84 
was managed in three different clinical areas in open six-bedded bays without 85 
infection control precautions. Clinicians must be aware of the possibility of COVID-19 86 
presenting non-specifically, including with delirium, particularly with signs suggesting 87 
infection, so cases are not missed when they fall outside current diagnostic and 88 
management guidelines. This has implications for the diagnosis and isolation of 89 
COVID-19 in frail older people, with potential for spread among healthcare 90 




1. World Health Organisation. WHO Director-General's opening remarks at the 95 
media briefing on COVID-19 - 11 March 2020 96 
https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-97 
the-media-briefing-on-covid-19---11-march-2020 Accessed 19 March 2020. 98 
2. Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in 99 
China. NEJM, 2020. doi: 10.1056/NEJMoa2002032 100 
3. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult 101 
inpatients with COVID-19 in Wuhan, China: a retrospective study. Lancet, 2020. doi: 102 
1016/S0140-6736(20)30566-3. 103 
 104 
4. World Health Organisation. Report of the WHO-China Joint Mission 105 
on Coronavirus Disease 2019 (COVID-19). https://www.who.int/docs/default-106 
source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf  107 
Figure1: CXR showing right upper and lower zones airspace opacification and small 108 
bilateral effusion. 109 
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